Benjamin Graham fit · Investissement defensive deep-value
Is CytomX Therapeutics, Inc. (CTMX) a Benjamin Graham Stock?
Meets only 3/7 Graham criteria — likely overpriced or unstable.
22/100
FPas un fit
3/7 critères validés
Les critères de Benjamin Graham, appliqués à CTMX
P/E ≤ 15
clé—
P/B ≤ 1.5
clé0.0x
Current ratio ≥ 2
3.6x
Debt / Equity ≤ 1
0.0x
Comment CTMX se classe selon d'autres stratégies
Données financières en direct
Cap. boursière
$969.17M
PER (TTM)
14.2x
ROIC (TTM)
62.2%
Marge brute
100.0%
Questions fréquentes
What is CTMX's Benjamin Graham fit score?
CTMX scores 22/100 on our Benjamin Graham fit engine — grade F. Meets only 3/7 Graham criteria — likely overpriced or unstable.
Does Benjamin Graham actually own CTMX?
Our score is computed from financial fundamentals against Benjamin Graham's published criteria. We don't claim that Benjamin Graham personally owns or recommends CTMX.
How often is this score updated?
CTMX's Benjamin Graham fit score is recomputed daily from the latest TTM financials.
Outil éducatif, pas un conseil en investissement. Les scores sont calculés à partir de données financières publiques selon les critères publiés de chaque stratégie d'investissement. Nous ne prétendons pas que Benjamin Graham possède ou recommande CTMX personnellement.